{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T02:08:01Z","timestamp":1706321281869},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[1986,12,1]],"date-time":"1986-12-01T00:00:00Z","timestamp":533779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1986,12]]},"DOI":"10.1007\/bf01785706","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T03:19:56Z","timestamp":1119237596000},"page":"1261-1266","source":"Crossref","is-referenced-by-count":6,"title":["Ciamexone, a highly selective immunomodulator \u2014 A tool for autoimmune diseases?"],"prefix":"10.1007","volume":"64","author":[{"given":"U.","family":"Bicker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.","family":"Usadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01785706_CR1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(85)91843-4","volume":"II","author":"IE Bantavala","year":"1985","unstructured":"Bantavala IE, Schernthaner G, Schober E, De Silva LM, Bryant J, Borkenstein M, Brown D, Menser MA (1985) Coxsackie B mumps, rubella and cytomegalo virus specific IgM responses in patients with juvenile-onset-insulin dependent diabetes mellitus in Britain, Austria and Australia. Lancet II:1409\u20131412","journal-title":"Lancet"},{"key":"BF01785706_CR2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/eji.1830111119","volume":"11","author":"A Ben-Nun","year":"1981","unstructured":"Ben-Nun A, Cohen JR (1981) Vaccination against autoimmune encephalomyelitis (EAE): Attenuated autoimmune T-lymphocytes confer resistance to induction of active EAE but not to EAE mediated by the intact T-lymphocyte line. Europ J Immunol 11:949\u2013952","journal-title":"Europ J Immunol"},{"key":"BF01785706_CR3","first-page":"447","volume-title":"Immune modulation agents and their mechanisms","author":"U Bicker","year":"1984","unstructured":"Bicker U (1984) Immunopharmacological properties of 2-cyan-aziridine derivatives. In: Immune modulation agents and their mechanisms. Fenichel RL and Chirigos MA. Marcel Dekker Inc. New York and Basel, pp 447\u2013473"},{"key":"BF01785706_CR4","first-page":"279","volume":"10","author":"U Bicker","year":"1974","unstructured":"Bicker U, Fuhse P (1974) Carcinostatic action of 2-cyanaziridine against sarcoma in rats. Exp Path 10:279\u2013284","journal-title":"Exp Path"},{"key":"BF01785706_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/08923978409026458","volume":"6","author":"U Bicker","year":"1984","unstructured":"Bicker U, Friedberg KD, Isert B, Mengel U (1984) Comparative investigations of various immunoregulatory substances in the delayed type hypersensitivity test of the mouse. J Immunopharmacol 6:57\u201367","journal-title":"J Immunopharmacol"},{"key":"BF01785706_CR6","first-page":"746","volume":"32","author":"U Bicker","year":"1982","unstructured":"Bicker U (1982) Effect of the immunomodulant 2-cyan-aziridine derivate BM 41.332 on the adjuvant arthritis in the rats. Drug Res 32:746\u2013752","journal-title":"Drug Res"},{"key":"BF01785706_CR7","unstructured":"Boehringer Mannheim GmbH (1986) Expos\u00e9 Ciamexone"},{"key":"BF01785706_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF03216222","volume":"21","author":"G Boitard","year":"1981","unstructured":"Boitard G, Debray-Sacks M, Pouplard A, Assam R, Hamburger J (1981) Lymphocytes from diabetes suppress insulin release in vitro. Diabetologica 21:41\u201346","journal-title":"Diabetologica"},{"key":"BF01785706_CR9","unstructured":"Boots company unpublished data"},{"key":"BF01785706_CR10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","volume":"II","author":"GF Bottazzo","year":"1974","unstructured":"Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet cell antibodies in diabetes mellitus associated with autoimmune polyendocrine deficiencies. Lancet II:1279\u20131283","journal-title":"Lancet"},{"key":"BF01785706_CR11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJM198508083130604","volume":"313","author":"GF Bottazzo","year":"1985","unstructured":"Bottazzo GF, Dean BM, McNally IM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. New Engl J Med 313:353\u2013360","journal-title":"New Engl J Med"},{"key":"BF01785706_CR12","first-page":"109","volume":"6","author":"D Brackertz","year":"1980","unstructured":"Brackertz D et al. (1980) Levamisol: Modulation der zellvermittelten Immunit\u00e4t vom verz\u00f6gerten Typ sowie der Antigen-induzierten Arthritis bei M\u00e4usen. Verh Dtsch Ges Rheumatol 6:109\u2013113","journal-title":"Verh Dtsch Ges Rheumatol"},{"key":"BF01785706_CR13","first-page":"27","volume":"8","author":"MA Chirigos","year":"1986","unstructured":"Chirigos MA, Schlick E, Saito T, Gruys E (1986) Biological response modifiers: Regulators of the cellular immune system and adjuvant in antitumor therapy. Meth Find Exptl Clin Pharmacol 8:27\u201333","journal-title":"Meth Find Exptl Clin Pharmacol"},{"key":"BF01785706_CR14","first-page":"160","volume-title":"Prostaglandins and immunity","author":"MA Chirigos","year":"1985","unstructured":"Chirigos MA, Schlick E, Hartung K (1985) Regulation of prostaglandin synthesis by biological response modifiers and effect on natural killer cell and bone marrow. In: Goodwin JS (ed) Prostaglandins and immunity. Martinius Nijhoff, Boston Dordrecht Lancaster, pp 160\u2013178"},{"key":"BF01785706_CR15","first-page":"603","volume":"123","author":"H Deicher","year":"1981","unstructured":"Deicher H (1981) Arthritis: Modelle und Pathomechanismen. M\u00fcnch Med Wochenschr 123:603\u2013605","journal-title":"M\u00fcnch Med Wochenschr"},{"key":"BF01785706_CR16","first-page":"47","volume":"2","author":"MG Dobersen","year":"1985","unstructured":"Dobersen MG (1985) Humoral autoimmune aspects of insulin-dependent (Type I) diabetes mellitus. Concepts Immunopathol 2:47\u201364","journal-title":"Concepts Immunopathol"},{"key":"BF01785706_CR17","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4049\/jimmunol.130.4.1723","volume":"130","author":"ME Elder","year":"1983","unstructured":"Elder ME, MacLaren NK (1983) Identification of profound peripheral T-lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. J Immunol 130:1723\u20131731","journal-title":"J Immunol"},{"key":"BF01785706_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(86)91943-4","volume":"I","author":"G Fentren","year":"1986","unstructured":"Fentren G, Assan R, Karsenty G, Du Rostu H, Sirmai J, Papoz L, Vialettes B, Vexian P, Rodier M, Lallemand A, Bach JF (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicenter double-blind-trial. Lancet I:119\u2013123","journal-title":"Lancet"},{"key":"BF01785706_CR19","unstructured":"Friedberg KD et al. (unpublished data)"},{"key":"BF01785706_CR20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"W Gepts","year":"1965","unstructured":"Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619\u201333","journal-title":"Diabetes"},{"key":"BF01785706_CR21","first-page":"432","volume":"38","author":"B Graffenried von","year":"1986","unstructured":"von Graffenried B (1986) Cyclosporin in autoimmune disease. Prog Allergy 38:432\u2013435 (Kayer, Basel, ed: Borel JF)","journal-title":"Prog Allergy"},{"key":"BF01785706_CR22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0167-5699(83)90019-1","volume":"4","author":"G Harris","year":"1983","unstructured":"Harris G (1983) DNA damage and repair in immunologically active cells. Immunol Today 4:109\u2013112","journal-title":"Immunol Today"},{"key":"BF01785706_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/08923978509047632","volume":"7","author":"B Isert","year":"1985","unstructured":"Isert B, Mengel K, Bicker U, Friedberg KD (1985) The influence on the formation of instable haemoglobin by the immunomodulating 2-cyan-aziridine Azimexone and BM 41.332 in mice. J Immunopharmacol 7:179\u2013193","journal-title":"J Immunopharmacol"},{"key":"BF01785706_CR24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/diab.30.10.887","volume":"30","author":"R Jackson","year":"1981","unstructured":"Jackson R, Rassi N, Crump T, Haynes B, Eisenbarth GG (1981) The BB diabetic rat. Profound T-cell lymphopenia Diabetes 30:887\u2013889","journal-title":"Diabetes"},{"key":"BF01785706_CR25","unstructured":"Kadota K, Okuda T, Skamoto K, Nishikaku F, Koga Y (1986) Pharmacological investigation of Ciamexone (BM 41.332). Sumitomo Pharmaceuticals Co. Ltd. SRD 01788 reports"},{"key":"BF01785706_CR26","unstructured":"Kiesel U, Maruta K, Treichel U, Bicker U, Kolb H Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of Ciamexone. J Immunopharmacol (in press)"},{"key":"BF01785706_CR27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0167-5699(82)90015-9","volume":"3","author":"IG Knight","year":"1982","unstructured":"Knight IG (1982) Autoimmune diseases: Defects in immune specificity rather than a loss of suppressor cells. Immunol Today 3:326\u2013328","journal-title":"Immunol Today"},{"key":"BF01785706_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(83)91558-1","volume":"I","author":"A Laupacis","year":"1983","unstructured":"Laupacis A, Stiller CR, Gardell C, Deown P, Dupre J, Wallace AC (1983) Cyclosporin prevents diabetes in BB wister rats. Lancet I:10","journal-title":"Lancet"},{"key":"BF01785706_CR29","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1126\/science.388619","volume":"206","author":"AA Like","year":"1979","unstructured":"Like AA, Rossini AA, Guberski DL, Appel MC, Williams RM (1979) Spontaneous diabetes mellitus: reversal and prevention in the BB\/W rat with antiserum to rat lymphocytes. Science 206:1421\u20131423","journal-title":"Science"},{"key":"BF01785706_CR30","first-page":"93","volume":"7","author":"Th Linn","year":"1986","unstructured":"Linn Th, Bretzel RG, Federlin K (1986) Wirkungsvergleich von Ciclosporin A und Ciamexon am Low-Dose-Streptozotocin induziertem Diabetes mellitus. Akt Endokrinol Stoffw 7:93","journal-title":"Akt Endokrinol Stoffw"},{"key":"BF01785706_CR31","first-page":"121","volume":"111","author":"Th Linn","year":"1986","unstructured":"Linn Th, Germann H, Hering B, Bretzel R, Federlin K (1986) Ciamexone in low-dose streptozotocin induced diabetes mellitus. Acta Endocrinol 111:121\u2013122","journal-title":"Acta Endocrinol"},{"key":"BF01785706_CR32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4049\/jimmunol.122.4.1220","volume":"122","author":"N Manny","year":"1979","unstructured":"Manny N, Datta SK, Schwartz RS (1979) Synthesis of IgM by cells fo NZB and SWR mice and their crosses. J Immunol 122:1220\u20131227","journal-title":"J Immunol"},{"key":"BF01785706_CR33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00281296","volume":"22","author":"EB Marliss","year":"1982","unstructured":"Marliss EB, Nakooda AF, Poussier P, Sima AAF (1982) The diabetic syndrome of the BB wistar rat: possible relevance to type I (insulin-dependent) diabetes in man. Diabetologica 22:225\u2013232","journal-title":"Diabetologica"},{"key":"BF01785706_CR34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/287544a0","volume":"287","author":"RC Miller","year":"1980","unstructured":"Miller RC (1980) An Immunological Suppressor Cell Inactivating Cytoxic T-lymphocytes Percursor Cells Recognizing it. Nature 287:544\u2013546","journal-title":"Nature"},{"key":"BF01785706_CR35","unstructured":"Newsom-Davis J: personal communication"},{"key":"BF01785706_CR36","unstructured":"Nussenblatt RB: personal communication"},{"key":"BF01785706_CR37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0002-9394(80)90108-7","volume":"89","author":"RB Nussenblatt","year":"1980","unstructured":"Nussenblatt RB, Gery I, Ballintine RJ, Wacker WB (1980) Cellular immunity of uveitis patients to retinal S-antigen. Am J Opthalmol 89:173\u2013179","journal-title":"Am J Opthalmol"},{"issue":"4","key":"BF01785706_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/08923978109031062","volume":"3","author":"L Olsson","year":"1981","unstructured":"Olsson L, Bicker U (1981\/82) Effect of the immune modulators BM 12.531 (Azimexone) and BM 41.332 on the subset of T-lymphocytes in mice. J Immunopharmacol 3\/4:277\u2013289","journal-title":"J Immunopharmacol"},{"key":"BF01785706_CR39","first-page":"364","volume":"10","author":"V Patel","year":"1983","unstructured":"Patel V, Panayi G, Unger A (1983) Spontaneous and pokeweed mitogen induced in vitro immunoglobulin and IgM rheumatoid factor production by peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis. J Rheumatol 10:364\u2013372","journal-title":"J Rheumatol"},{"key":"BF01785706_CR40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/297066a0","volume":"297","author":"T Quodera","year":"1982","unstructured":"Quodera T, Ray VR, Melez KA, Suzuki H, Toniolo A, Notkins AL (1982) Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 297:66\u201368","journal-title":"Nature"},{"key":"BF01785706_CR41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0167-5699(85)90044-1","volume":"6","author":"HG Rammensee","year":"1985","unstructured":"Rammensee HG, Bevan MJ, Fiuh PJ (1985) Antigen specific suppression of T-cell responses \u2014 the veto concept. Immunol Today 6:41\u201343","journal-title":"Immunol Today"},{"key":"BF01785706_CR42","first-page":"67","volume":"23","author":"JM Roitt","year":"1984","unstructured":"Roitt JM (1984) Prevailing theories in autoimmune disorders. Triangle 23:67\u201376","journal-title":"Triangle"},{"key":"BF01785706_CR43","first-page":"436","volume":"338","author":"M Schmitz-Schumann","year":"1985","unstructured":"Schmitz-Schumann M (1985) Interim report of clinical studies presented at the International symposium on Ciclosporin in autoimmune diseases. Basel, March 18\u201320, Prog Allergy 338:436\u2013446 (Kasper, Basel 1986, Ed: Borel JF)","journal-title":"Prog Allergy"},{"key":"BF01785706_CR44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00252852","volume":"23","author":"TA Seemayer","year":"1982","unstructured":"Seemayer TA, Sch\u00fcrch W, Kalant N (1982) B-cell lymphoproliferation in spontaneously diabetic BB Wistar rats. Diabetologica 23:261\u2013265","journal-title":"Diabetologica"},{"key":"BF01785706_CR45","first-page":"109","volume":"6","author":"B St\u00f6ckmann","year":"1985","unstructured":"St\u00f6ckmann B, G\u00f6ke E, Siegel W, Creutzfeldt W (1985) Beeinflussung von B-Zellmorphologie und Insulinsekretion im Rattenpankreas durch Gabe von Cyclosporin A. Akt Endokrin Stoffw 6:109","journal-title":"Akt Endokrin Stoffw"},{"key":"BF01785706_CR46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(86)90128-5","volume":"II","author":"KH Usadel","year":"1986","unstructured":"Usadel KH, Teuber J, Schmeidl R, Schwedes U, Bicker U, Herz M (1986) Management of Type I Diabetes with Ciamexone. Lancet II:567","journal-title":"Lancet"},{"key":"BF01785706_CR47","first-page":"265","volume":"1","author":"J Vaughan","year":"1983","unstructured":"Vaughan J, Carson D, Fox R (1983) The Epstein Barr virus and rheumatoid arthritis. Clin exp Rheum 1:265\u2013272","journal-title":"Clin exp Rheum"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01785706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01785706\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01785706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T01:18:14Z","timestamp":1706318294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01785706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,12]]},"references-count":47,"journal-issue":{"issue":"24","published-print":{"date-parts":[[1986,12]]}},"alternative-id":["BF01785706"],"URL":"https:\/\/doi.org\/10.1007\/bf01785706","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,12]]}}}